ImpiloAmalungiselelo

"Alimta" (pemetrexed): the nozakwabo intengo. Lapho ukuthenga Alimta eshibhile?

"Alimta" (pemetrexed) - izidakamizwa anticancer ungaphakathi ngesimo lyophilisate (powder omisiwe ngendlela ekhethekile). Isetshenziselwa ukulungiselela isixazululo ukumnika emthanjeni.

Kokuqhubeka egazini ngemva ukuvuza, pemetrexed kwasakazwa sezitokisi lapho polyglutamate okusheshayo iguqulwe kwifomu okuyinto wasigcina nezicubu isimila, breaking nabo izinqubo umzimba nokuvimbela ukukhula kwabo.

Mayelana kusebenza kanjani izindlela isihloko futhi lapho izidakamizwa "Alimta" ukuthenga inzuzo, sizochaza kamuva kulesi sihloko.

Kuyini ejwayelekile, noma kuphi ukuthenga imithi, "Alimta" eshibhile

Veta, lapho kunokwenzeka izidakamizwa "Alimta" ukuthenga eshibhile, kubalulekile ukuba iziguli eziningi. Kwaziwa kahle kamhlophe ukuthi amanxusa anti-isimila iyabiza, futhi achazwe kulo magazini iyathinteka. Ngokwesibonelo, e Moscow, isibonelo, i-lyophilisate "Alimta" intengo igcinwe basukela 43 000 kuya 74 000 ruble.

Ukuze ugweme ukuchitha ngokweqile, iziguli zithole imithi ejwayelekile. Lokhu kusho, okukhiqizwa ngaphansi kwelayisensi, nokugcina esiqinile ubuchwepheshe, futhi ube isithako ezisebenzayo ezifanayo yegama lomkhiqizo izidakamizwa. intengo zabo ongaphakeme akuyona ngenxa ukungabi khona nomphumela ofiselekayo, kanye neqiniso lokuthi intengo engamenzi izindleko ukuthuthukiswa nokuhlonishwa kwemibhalo yalezi mithi emakethe.

WWW.ONKO24.COM Ngakho, kusayithi angathengwa ekhiqizwa eNdiya ngo Natco Pharma Ltd. echazwe amathuluzi ejwayelekile - Pemnat. izindleko zawo + ziyoba yinto lapha ruble 18 000. ibhodlela, okuyinto Yiqiniso, kuba ishibhile futhi othengekayo abantu ababhekene nesifo esibucayi ngayinye.

izinkomba

izidakamizwa ukwelashwa "Alimta" kufanele sigcwaliswe kuphela ngaphansi kokuqondisa onguchwepheshe onolwazi ukusebenza zabasiza abathile abanomdlavuza. pemetrexed zinikwa zokuba uchwepheshe wokuhlola izimila abulalayo emaphashini futhi bronchi, kanye ukuthola mesothelioma pleural.

Izimo futhi side effects

Contraindicated lyophilisate "Alimta" imfundo okuyinto ezihlongozwayo kule iphepha, abesifazane abakhulelwe kanye lactating, izingane (njengoba ukusetshenziswa kwayo kulezi ziguli engakaze wafunda), kanye labo babe hypersensitivity emuthini.

Phakathi ukwelashwa, imiphumela engemihle elandelayo kungenzeka ezigulini:

  • ukwephulwa kohlelo hematopoietic - leukopenia, ukuntuleka kwegazi emzimbeni, futhi neutropenia;
  • ukucanuzela kwenhliziyo, ukuhlanza,
  • ukuthuthukiswa anorexia;
  • ukuqubuka futhi desquamation kwesikhumba;
  • ukukhathala okusezingeni eliphezulu;
  • isifo sohudo,
  • ukuthuthukiswa pharyngitis.

Umthamo nomthamo ophezulu wemithi

"Alimta" iqondiswa njengenhlangano ukumnika emthanjeni imizuzu engaphezu 10.

Ekwelapheni izimila ebulalayo nonsmall umdlavuza cell wamaphaphu we pleura Kunconywa lokuqala umugqa yokwelapha lihambisana "cisplatin", iqondiswa 500 mg / m² zonke ngosuku lokuqala umjikelezo usuku 21. Ngalesi umthamo "Cisplatin" kufanele kube 75 mg / m² yaphinde yaphathwa njengenhlangano nekufakwa cishe isigamu sehora ngemva pemetrexed.

Lapho iqondiswa wedwa 500 mg / m² njalo ukulungiselela echazwe kuqala umjikelezo wosuku-21.

Indlela ukulungiselela isixazululo

Njengoba uketshezi for "Alimta" wasebenzisa izidakamizwa NaCl (0.9% isixazululo). Ukuze uthole siphelile izidakamizwa lyophilisate (100 mg) buhlanjululwe sodium chloride ukuba lokuhlushwa 25 mg / ml. Emva kwalokho isitsha unyakaza, futhi umphumela okufanele kube sobala, isixazululo kungekho nto enemibala emihle. ukushintshashintsha OKUVUMELEKILE umbala walo ophuzi noma ophuzi.

Isixazululo wafakwa okwengeziwe buhlanjululwe pemetrexed kumele sodium chloride isixazululo ukuthola ivolumu 100 ml. A ngaphambi kokwenziwa kumele zihlolwe ukuze khona izinhlayiya zingaxazululeki futhi ashintshe umbala.

Ngokusho exhunywe izidakamizwa "Alimta" ukufundiswa ukuze usebenzise izimali kufanele kube amahora kungakadluli 24 emva ukupheka.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 zu.atomiyme.com. Theme powered by WordPress.